HIGHLIGHTS
- who: BRIEF COMMUNICATION and colleagues from the (UNIVERSITY) have published the article: The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype, in the Journal: (JOURNAL) of March/15,/2019
- how: The data generated and analyzed during this study are described in37 and correspond to 36 publicly available datasets that are listed in Supplementary Table 8 (all datasets) and in data refs 711283438-105.
- future: Validation in prospective clinical trials is warranted and caution is required in the interpretation of ongoing trials and the design of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.